Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Why ?10M, even if true, that's not reflective of the capital raises they have done in the past year. They have been going quarter by quarter in anticipation of FDA approval. So what is that? Was there a milestone payment from Par, warrants exercised? I'll believe the secondary when I see it, but I don't expect it.
Where is it because I don't see it.
I actually have a pretty good analogy to these boards and investing in general.
We're all on the same ship trying to make money buy buying selling, shorting, etc... We are just in different departments. Departments unique to the function of the goals of that department, but they function all together as the crew of the ship which is likened to the overall markets. Sometimes the seas a re rough and sometimes they are calm bit everyone is all in the same ship, trying to ride the ways and make it to home port. To make a profit.
How ever many shares he may have, John Howell resigned. That is a fact, and he didn't do anything of significant value for Arrayit Diagnostics at that time.
John Howell wasted much time and Diagnostics effort scheming to defraud the company, which did not work.
Arrayit is trading at higher volumes now and at a higher price with more transparency, this does well for their credibility. The future is bright for the company which is reflected in the most recent capital raises, company headquarter upgrade and continued diagnostics developments.
There are investors loading up on stock. You can tell by the size of the bids. Arrayit is all growth. It's a patient mans stock.
Profit taking is driving the price downward.
Oh no, scandal? Fraud, what going on here. Lol.
I like the new average shares traded we have now, definitely a change from a few months ago.
I'm not certain,but based on current information, the 15 and 30mg strengths have about a third of total Focalin sales, and with then180 day exclusivity to potentially bring in a profit of over $200M within those six months, and, with The profit sharing agreement between Par And Intelli; Par has a majority on profits from sales, so it's safe to assume that the profit split may be at least 60/40. It can vary, but it depends on the contract agreement.
When IPCI starts to book revenues from Par PHA payments to them then we can know for sure. But rest assured it is revenue is imminent and significant, and these stock levels are toast.
Dr. Odidi mentioned about IPCI financial flexibility with this approval, that is just ONE approval. Last time I check they still had 7 more in review, with I believe two over 40 months now.
We should also here about the Rexista phase study shortly.
If rumors are working to bring down the stock then I'm glad the weaklings are out.
I haven't received a reply as of yet.
One thing should be clear bough. Par already started shipment of Generic Focalin, so we can start seeing some revenue soon.
Even if there was an offering, it would really have much of an impact of the share structure and may actually be good right now. The company has been intelligent with managing the finances. Hats of to Mr Rampertb.
I know it was BS. I contacted the company for clarification on a few things and I think that a pullback today was expected, but I'm loving the frequency of trades and the volume. It great to see. Long gone are the days of trading under 100,000 shares per day. Record volume just this week.
My crystal ball says this is just the beginning for IPCI.
Post the twitter comment.
Great news.
Can you elaborate on your comment please?
A pullback is expected. People need their profits.
I'm glad the investors who held this stock for years for this moment are rewarded!
Wow, that's great. Hmmm...who's buying at those prices?
There's currently a 50,000 share bid. Who buys 50,000 shares at these levels?? Large block buys it higher levels is a GREEN flag. Picking apart filings is frivolous, unless you are a legal consultant or accountant for the company. One particular area,
In my opinion I'm interested in hearing more about is the ongoing relationship with Avant Diagnostics.
What is going on with Mr. Scott and Mr. Lin. Seems like there are not very good at what they do.
I'm looking forward to seeing some interior pictures of the new facility.
The expansion to a facility TWICE the size as the current one is definitely a sign of growth.
When company outgrow their current residence, the must move to enable growth!
100 per share? That would place the market cap over $2billion!
I don't know?
But, it's possible if they secure about 4 - 5 more approvals.
That's why I haven't sold anything yet. Anything under 15 dollars is small potatoes to me Doog.
You were the one who definitely didn't waiver in the fact that the would receive FDA approval. My hat off to you sir!
Wow, what an open. I was able to get in some more shares this morning and already up on that position in addition to my long term holdings. Great day!
I would like to know as well.
The rest of us knew what you were talking about.
Bingo!
I'm also looking forward to a future PR about the Excalibur test, and human allergy test.
The highest price target so far is $9.00.
If you reflect back to the IPCI corporate presentations, and check the figures for the projected revenues from the marketed ANDA and NDA drugs; it can give you some insight into the future valuation.
The revenue targets are in the hundreds of millions of dollars. The share price now is small potatoes for the true longs. That's why the volume today was more than the total outstanding shares. Large market players were watching IPCI for a while and pulled the trigger.
I have been guilty of reflecting on past hurdles the company has had, but one thing that is evident is that FACT, that they received financing that is clearly targeted to expansion, they added a new board member and they are upgrading the facility. These are materially significant events that validate the pre-IDE FDA submission, CLIA, and ISO, certification. With the help of DOCRO in this capacity will bring more credibility and attract other investors.
The key validating sentence of the PR about why they are moving to a larger facility. Growth and expansion, and the upgrade to a molecular diagnostics company. See the vision they are trying to communicate here!
From today's PR:
As previously announced, Arrayit will utilize DOCRO-facilitated CLIA and ISO 9001 and ISO 13485 certified laboratories in its new company headquarters in Sunnyvale, California, USA for the OvaDx® and PDx™ FDA submission processes and for processing patient test samples upon FDA approval and commercialization.
In the 3rd Q Arrayit posted a net profit. This should add to the EPS and valuation.
We have heard it from the horses moth that is validated by previous action with financing, upgraded facilities and the addition of a accredited Director. OvaDx is top priority and I actually now beleive that they will shoot for pre-IDE in the first half of 2014. The stock will be trading in the dollars by then.
Today's volume was tremendous. I stepped away for a few hours and came back to see it at 5 dollars and record breaking values that would rival a blue chip stock.
What is this company all about. Just found it and haven't done any Dd yet. Anyone care to give a quick run-down
Just t
Hit the 52 week high!
A great open today!
Remember in an interview from, I think 2011, Dr. Isa Odidi, the CEO, said that he saw the company with a market cap of a billion dollars in five years. Seems that can be a reality.
Definitely agree, but I think they will continue to grow independently.
Great news everyone. Rode this baby for over a year to this moment. Hopefully this is the first of many. I'm going to be looking for a lot more press releases from IPCI going forward about developments wig Generic FocalinXR, partnerships for the other drugs, and entering into profitability. Great day! Absolutely.
I'm thinking financing news though
Excuse me, 'where'